A Look at Teva's Dominance in the Biosimilar Space
Teva withdraws US filing for cancer biologic - PMLiVE
Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals
LONQUEX 10 MG/ML SOLUÇÃO INJETÁVEL COM 1 SERINGA PREENCHIDA DE 0,6 ML - LIPEGFILGRASTIM - TEVA (REFRIGERADO) - Ative Medicamentos
Lipegfilgrastim (Lonquex) • Arznei-News
Filgrastim-Teva 48 Mio E/0.8ml 5 Fertspr 0.8 ml
Lipegfilgrastim
Medicamentos
Efficacy and safety of lipegfilgrastim compared with placebo in patients with non-small cell lung cancer receiving chemotherapy: post hoc analysis of elderly versus younger patients | Request PDF
Lonquex
Article: Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients (full text) - September 2020 - NJM
Teva macht Neulasta Konkurrenz | APOTHEKE ADHOC
Covid 疫苗,中國的CoronaVac 對世衛組織沒問題- 開始雜誌
LONQUEX leaflet 6mg x1 INJECTIBLE SOLUTION TEVA 1972.52 RON for phy...
Lonquex® 6 mg 1 St - shop-apotheke.com
Lonquex 6 mg Injektionslosung in einer Fertigspritze